Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs

studies utilizing a human lung A549 xenograft mouse model demonstrated that concomitant treatment with etoposide and Gal-ARV-771 leads to a significant inhibition of tumor growth without eliciting significant toxicity.